Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Care | Research article

Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trial

Authors: Esther du Pon, Nanne Kleefstra, Frits Cleveringa, Ad van Dooren, Eibert R. Heerdink, Sandra van Dulmen

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Diabetes self-management education can be helpful for patients with type 2 diabetes in managing their condition. We aimed to study the effects of the group-based PRoactive Interdisciplinary Self-MAnagement (PRISMA) training program on self-reported and clinical outcomes in patients with type 2 diabetes treated in general practice.

Methods

Persons aged 18 years or older diagnosed with type 2 diabetes and treated in primary care were included. In a randomized controlled trial design (1:1), patients were followed for 6 months with an extension phase of 6 months. Block randomization was used. The patients with type 2 diabetes received either PRISMA in addition to usual care or usual care only. All patients completed a range of validated questionnaires (including knowledge, skills, and confidence for self-management [PAM], diabetes self-care behavior [SDSCA], health-related quality of life [EQ-5D], and emotional well-being [WHO-5]). In addition, clinical outcomes (HbA1c, body mass index, systolic blood pressure, and cholesterol levels) were collected during the routine diabetes checkups.

Results

Of the total sample (n = 193), 60.1% were men. The mean age was 69.9 years (SD = 9.1). No significant differences were found on self-reported outcomes between the groups at 0, 6, and 12 months. The clinical outcomes were not reported due to a large number of missing values.

Conclusion

PRISMA did not improve self-reported outcomes in patients with type 2 diabetes treated in primary care. It was not possible to make a statement about the clinical effects.

Trial registration

date: 16/07/2014, number: NL4550 (https://​www.​trialregister.​nl/​trial/​4550).
Appendix
Available only for authorised users
Literature
2.
go back to reference Kleefstra N, Landman GW, Van Hateren KJ, Meulepas M, Romeijnders A, Rutten GE, et al. Dutch diabetes prevalence estimates (DUDE-1). J Diabetes. 2016;8:863–5.CrossRef Kleefstra N, Landman GW, Van Hateren KJ, Meulepas M, Romeijnders A, Rutten GE, et al. Dutch diabetes prevalence estimates (DUDE-1). J Diabetes. 2016;8:863–5.CrossRef
3.
go back to reference Lemmens L, Spreeuwenberg P, Rijken M. Kerngegevens Zorg 2007: Nationaal Panel Chronisch zieken en gehandicapten. Nivel: Utrecht; 2008. Lemmens L, Spreeuwenberg P, Rijken M. Kerngegevens Zorg 2007: Nationaal Panel Chronisch zieken en gehandicapten. Nivel: Utrecht; 2008.
4.
go back to reference Koch T, Jenkin P, Kralik D. Chronic illness self-management: locating the “self”. J Adv Nurs. 2004;48:484–92.CrossRef Koch T, Jenkin P, Kralik D. Chronic illness self-management: locating the “self”. J Adv Nurs. 2004;48:484–92.CrossRef
5.
go back to reference Lorig K, Holman H. Arthritis self-management studies: a twelve-year review. Health Educ Q. 1993;20:17–28.CrossRef Lorig K, Holman H. Arthritis self-management studies: a twelve-year review. Health Educ Q. 1993;20:17–28.CrossRef
6.
go back to reference Hendriks SH, van Hateren KJ, Groenier KH, Houweling ST, Maas AH, Kleefstra N, et al. Sex differences in the quality of diabetes Care in the Netherlands (ZODIAC-45). PLoS One. 2015;10:e0145907.CrossRef Hendriks SH, van Hateren KJ, Groenier KH, Houweling ST, Maas AH, Kleefstra N, et al. Sex differences in the quality of diabetes Care in the Netherlands (ZODIAC-45). PLoS One. 2015;10:e0145907.CrossRef
7.
go back to reference Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33:74–109.CrossRef Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33:74–109.CrossRef
8.
go back to reference Roebuck MC, Liberman JN, Gemill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30:91–9.CrossRef Roebuck MC, Liberman JN, Gemill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30:91–9.CrossRef
9.
go back to reference White AJS, Kellar I, Prevost AT, Kinmonth AL, Sutton S, Canny M, et al. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. Prim Care Diabetes. 2012;6:27–33.CrossRef White AJS, Kellar I, Prevost AT, Kinmonth AL, Sutton S, Canny M, et al. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. Prim Care Diabetes. 2012;6:27–33.CrossRef
10.
go back to reference Rubin RR, Anderson RM, Funnell MM. Collaborative DiabetesCare. Pract Diebetol. 2002;21:29–32. Rubin RR, Anderson RM, Funnell MM. Collaborative DiabetesCare. Pract Diebetol. 2002;21:29–32.
11.
go back to reference World Health Organization. Implementation tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva 2013. World Health Organization. Implementation tools: Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva 2013.
12.
go back to reference Leibbrandt A, Kiefte-de Jong J, Hogenelst M, et al. Effects of the PRo-active interdisciplinary self-MAnagement (PRISMA, Dutch DESMOND) program on dietary intake in type 2 diabetes outpatients: a pilot study. Clin Nutr. 2010;29:199–205.CrossRef Leibbrandt A, Kiefte-de Jong J, Hogenelst M, et al. Effects of the PRo-active interdisciplinary self-MAnagement (PRISMA, Dutch DESMOND) program on dietary intake in type 2 diabetes outpatients: a pilot study. Clin Nutr. 2010;29:199–205.CrossRef
13.
go back to reference Funnell M, Brown TL, Childs BP, Childs BP, Haas LB, Hosey GM, et al. National Standards for diabetes self-management education. Diabetes Care. 2012;35(Suppl 1):S101–8.CrossRef Funnell M, Brown TL, Childs BP, Childs BP, Haas LB, Hosey GM, et al. National Standards for diabetes self-management education. Diabetes Care. 2012;35(Suppl 1):S101–8.CrossRef
14.
go back to reference Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99:926–43.CrossRef Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99:926–43.CrossRef
15.
go back to reference Odgers-Jewell K, Ball LE, Kelly JT, Isenring EA, Reidlinger DP, Thomas R. Effectiveness of group-based self-management education for individuals with type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet Med. 2017;34:1027–39.CrossRef Odgers-Jewell K, Ball LE, Kelly JT, Isenring EA, Reidlinger DP, Thomas R. Effectiveness of group-based self-management education for individuals with type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet Med. 2017;34:1027–39.CrossRef
16.
go back to reference Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J. 2008;36:491–5.CrossRef Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J. 2008;36:491–5.CrossRef
17.
go back to reference Gillet M, Dallosso H, Dixon S, Brennan A, Carey ME, Campbell MJ, et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ. 2010;341:c4093.CrossRef Gillet M, Dallosso H, Dixon S, Brennan A, Carey ME, Campbell MJ, et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ. 2010;341:c4093.CrossRef
18.
go back to reference van Vugt M, de Wit M, Bader S, Snoek FJ. Does low well-being modify the effects of PRISMA (Dutch DESMOND), a structured self-management-education program for people with type 2 diabetes? Prim Care Diabetes. 2016;10:103–10.CrossRef van Vugt M, de Wit M, Bader S, Snoek FJ. Does low well-being modify the effects of PRISMA (Dutch DESMOND), a structured self-management-education program for people with type 2 diabetes? Prim Care Diabetes. 2016;10:103–10.CrossRef
19.
go back to reference du Pon E, Kleefstra N, van Dooren AA, Bilo HJG. Kruitwagen CLJJ, van Dulmen AM. DESTINE: a practice-based intervention to increase empowerment in patients with type 2 diabetes - a study protocol of a randomized controlled trial. Diabetes Manag 2017;7:330–336. du Pon E, Kleefstra N, van Dooren AA, Bilo HJG. Kruitwagen CLJJ, van Dulmen AM. DESTINE: a practice-based intervention to increase empowerment in patients with type 2 diabetes - a study protocol of a randomized controlled trial. Diabetes Manag 2017;7:330–336.
20.
go back to reference Du Pon E, El Azzati S, van Dooren A, Kleefstra N, Heerdink E, van Dulmen S. Effects of a Proactive interdisciplinary self-management (PRISMA) program on medication adherence in patients with type 2 diabetes in primary care: a randomized controlled trial. Patient Prefer Adherence. 2019;13:749–59.CrossRef Du Pon E, El Azzati S, van Dooren A, Kleefstra N, Heerdink E, van Dulmen S. Effects of a Proactive interdisciplinary self-management (PRISMA) program on medication adherence in patients with type 2 diabetes in primary care: a randomized controlled trial. Patient Prefer Adherence. 2019;13:749–59.CrossRef
21.
go back to reference Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.CrossRef Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.CrossRef
22.
go back to reference Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in the Netherlands: translation and validation of the American short form patient activation measure (PAM13). BMC Public Health. 2012;12:577.CrossRef Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in the Netherlands: translation and validation of the American short form patient activation measure (PAM13). BMC Public Health. 2012;12:577.CrossRef
23.
go back to reference Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRef Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRef
24.
go back to reference Johnson SB. Methodological issues in diabetes research: measuring adherence. Diabetes Care. 1992;15:1658–67.CrossRef Johnson SB. Methodological issues in diabetes research: measuring adherence. Diabetes Care. 1992;15:1658–67.CrossRef
25.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P. Parkin D et all. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P. Parkin D et all. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRef
26.
go back to reference Bech P, Raabaaek Olsen L, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. Int J Methods Psychiatr Res. 2006;2:85–91. Bech P, Raabaaek Olsen L, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. Int J Methods Psychiatr Res. 2006;2:85–91.
27.
go back to reference Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE. Long-term effects of self- management education for patients with type 2 diabetes taking maximaloral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med. 2004;21:491–6.CrossRef Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE. Long-term effects of self- management education for patients with type 2 diabetes taking maximaloral hypoglycaemic therapy: a randomized trial in primary care. Diabet Med. 2004;21:491–6.CrossRef
28.
go back to reference Altenhofen L, Brenner G, Haβ W, Siering U. [Quality Assurance Report 2004, Disease-Management-Programs in North Rhine.] Available: http://www.kvno.de/downloads/quali/qualbe_dmp04.pdf. 2004. Accessed 21 October 2019. Altenhofen L, Brenner G, Haβ W, Siering U. [Quality Assurance Report 2004, Disease-Management-Programs in North Rhine.] Available: http://​www.​kvno.​de/​downloads/​quali/​qualbe_​dmp04.​pdf.​ 2004. Accessed 21 October 2019.
29.
go back to reference Icks A, Rathmann W, Haastert B, Mielck A, Holle R, et al. Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000. Dtsch Med Wochenschr. 2006;131:73–8.CrossRef Icks A, Rathmann W, Haastert B, Mielck A, Holle R, et al. Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000. Dtsch Med Wochenschr. 2006;131:73–8.CrossRef
30.
go back to reference Vernooij-Dassen M, Moniz-Cook E. Raising the standard of applied dementia care research: addressing the implementation error. Aging Ment Health. 2014 Sep;18:809–14.CrossRef Vernooij-Dassen M, Moniz-Cook E. Raising the standard of applied dementia care research: addressing the implementation error. Aging Ment Health. 2014 Sep;18:809–14.CrossRef
Metadata
Title
Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trial
Authors
Esther du Pon
Nanne Kleefstra
Frits Cleveringa
Ad van Dooren
Eibert R. Heerdink
Sandra van Dulmen
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0466-0

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue